Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

CytRx begins pharmacokinetic bafetinib trial in patients with brain cancer

Nov. 12, 2010

Canadian scientists identify new antimitotic agents

Nov. 12, 2010

Novel mTOR inhibitors presented by Merck & Co.

Nov. 12, 2010

Choongwae Pharma claims new reverse-turn mimetics for treatment of AML

Nov. 12, 2010

Clavis Pharma and Clovis Oncology sign additional agreement for CP-4126

Nov. 12, 2010

Novartis discontinues clinical program for anticancer candidate ASA-404

Nov. 12, 2010

Astex's AT-9283 enters phase II trial in multiple myeloma

Nov. 12, 2010

SuperGen discontinues development of SGI-1776 due to toxicity results

Nov. 11, 2010

Eusa Pharma submits BLA to FDA for Erwinase in acute lymphoblastic leukemia

Nov. 11, 2010

Merck KGaA patents new E-NPP 2 inhibitors

Nov. 11, 2010

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...